EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Resistance to First-Line Therapy in Clinical Anaerobic Isolates from Southern Croatia

Karla Kristicevic, József Sóki, Marijeta Gotovac, Antonija Saskor, Zana Rubic, Domagoj Drenjancevic, Marko Zivkov, Maja Bogdan, Ivana Goic-Barisic, Marija Tonkic, Anita Novak

Microbiology Research · 09.11.2026 · 17 (11) · 224

DOI: 10.3390/microbiolres17110224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Research, online erschienen am 09.11.2026. Verfasst von Karla Kristicevic und 10 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study analyzed phenotypic and genotypic antimicrobial resistance (AMR) among commonly isolated anaerobes from southern Croatia. Over two years, 176 isolates (Bacteroides spp., Prevotella spp. and Finegoldia magna) were tested for antimicrobial susceptibility by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) disk diffusion method. A subset of twenty-four of clindamycin- and/or metronidazole-resistant isolates (22 Bacteroides, along with one Prevotella bivia and one Finegoldia magna) underwent real-time PCR for resistance genes. Resistance of Bacteroides spp. in the total cohort to piperacillin/tazobactam, meropenem, clindamycin and metronidazole was 2.3%, 6.3%, 49.2%, and 10.2%, respectively. Among Prevotella spp. resistance to penicillin, piperacillin/tazobactam and clindamycin were 54.8%, 6.5%, and 67.7%, respectively. Of all Finegoldia magna isolates, 11.8%, 47.1% and 11.8% were resistant to penicillin, clindamycin and metronidazole. Non-fragilis Bacteroides spp. showed significantly higher resistance rates for clindamycin in comparison to B. fragilis, (36/52; 69.2% vs. 27/76; 35.5%, Fisher’s exact test p = 0.000282). For 22 selected clindamycin- and/or metronidazole-resistant Bacteroides spp., the prevalence of the cepA, cfxA, cfiA, ermF and ermG genes was 54.6%, 45.5%, 4.5%, 63.6% and 4.5%. None of the screened isolates carried the crxA, blaOXA-347, or nim genes. The cfiA gene was detected in one meropenem-resistant B. fragilis isolate, but lacked an associated insertion sequence. Prevotella bivia harbored both cfxA and ermF, while Finegoldia magna carried only ermF. These findings demonstrate substantial resistance rates to first-line antibiotics, emphasizing the urgency of ongoing AMR surveillance with a renewed focus on neglected anaerobic pathogens and the expansion of routine susceptibility testing to additional antimicrobials.

Zitieren

APA

Kristicevic, K., Sóki, J., Gotovac, M., Saskor, A., Rubic, Z., Drenjancevic, D., Zivkov, M., Bogdan, M., Goic-Barisic, I., Tonkic, M., & Novak, A. (2026). Antimicrobial Resistance to First-Line Therapy in Clinical Anaerobic Isolates from Southern Croatia. Microbiology Research, 17(11), 224. https://doi.org/10.3390/microbiolres17110224

Vancouver

Kristicevic K, Sóki J, Gotovac M, Saskor A, Rubic Z, Drenjancevic D, et al. Antimicrobial Resistance to First-Line Therapy in Clinical Anaerobic Isolates from Southern Croatia. Microbiology Research. 2026;17(11):224. doi:10.3390/microbiolres17110224

BibTeX
@article{Kristicevic2026,
  author = {Kristicevic, Karla and Sóki, József and Gotovac, Marijeta and Saskor, Antonija and Rubic, Zana and Drenjancevic, Domagoj and Zivkov, Marko and Bogdan, Maja and Goic-Barisic, Ivana and Tonkic, Marija and Novak, Anita},
  title = {Antimicrobial Resistance to First-Line Therapy in Clinical Anaerobic Isolates from Southern Croatia},
  journal = {Microbiology Research},
  year = {2026},
  volume = {17},
  number = {11},
  pages = {224},
  doi = {10.3390/microbiolres17110224}
}
Kostenlos starten →